Cardiovascular Outcomes in Thyroid Cancer Patients Treated with Thyroidectomy: A Meta-analysis

  • Lee, E.K.
  • Ahn, H.Y.
  • Ku, E.J.
  • Yoo, W.S.
  • Lee, Y.K.
  • 외 4명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

18

초록

Context: Thyroid dysfunction is associated with an increased risk of cardiovascular disease (CVD) in the general population; however, it remains controversial whether differentiated thyroid cancer (DTC) treatment, including thyroidectomy and thyroid-stimulating hormone suppression, further increases the risk of CVD. Objective: This study aimed to evaluate the risk of CVD in patients with DTC. Methods: We performed a review of observational studies on associations between DTC and cardiovascular outcomes, indexed in MEDLINE, Embase, and Web of Science. We excluded studies that evaluated CVD as comorbidity before DTC diagnosis and those that used active surveillance without thyroidectomy as an intervention. Risk estimates were pooled using random-and fixed-effects models when 3 or more studies reported on the outcome of interest. Echocardiographic and hemodynamic parameters were examined. Results: Eighteen studies were included in the quantitative analysis (193 320 cases with DTC and 225 575 healthy controls). DTC was associated with an increased risk of atrial fibrillation (pooled risk ratio [RR] = 1.55 [95% CI: 1.30-1.84]), coronary artery disease (RR = 1.10 [1.00-1.21]), cerebrovascular accidents (RR = 1.15 [1.09-1.20]), and all-cause mortality (RR = 1.95 [1.03-3.69]). DTC was associated with higher diastolic blood pressure (standardized mean difference [SMD], 0.22 [0.01-0.42]), heart rate (0.37 [0.17-0.57]), left ventricular mass index (0.66 [0.45-0.88]), and interventricular septal thickness (0.91 [0.33-1.49]) and lower early to late ventricular filling velocities (-0.42 [-0.79 to-0.05]), but not with ejection fraction. Conclusion: Patients with DTC are at an increased risk of atrial fibrillation, CVD, increased heart rate, and left ventricular mass development. © 2021 The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

키워드

cardiovascular diseasedifferentiated thyroid cancerthyroid-stimulating hormone suppressionTHYROTROPIN-SUPPRESSIVE THERAPYTERM OVERT HYPOTHYROIDISMCORONARY-HEART-DISEASEDIASTOLIC DYSFUNCTIONATRIAL-FIBRILLATIONRISKLEVOTHYROXINETHYROXINEMORTALITYCARCINOMA
제목
Cardiovascular Outcomes in Thyroid Cancer Patients Treated with Thyroidectomy: A Meta-analysis
저자
Lee, E.K.Ahn, H.Y.Ku, E.J.Yoo, W.S.Lee, Y.K.Nam, K.-H.Chai, Y.J.Moon, S.Jung, Y.-S.
DOI
10.1210/clinem/dgab576
발행일
2021-12
유형
Article
저널명
Journal of Clinical Endocrinology and Metabolism
106
12
페이지
3644 ~ 3654